Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes
Not Applicable
- Conditions
- Type 1 diabetes
- Registration Number
- JPRN-UMIN000013817
- Lead Sponsor
- The Jikei University School of Medicine Japan Diabetes Foundation
- Brief Summary
Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study. Onda Y, Nishimura R, Ando K, Takahashi H, Tsujino D, Utsunomiya K. Diabetes Res Clin Pract. 2016 Oct;120:149-55. doi: 10.1016/j.diabres.2016.07.019.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Type 2 diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Continuous glucose value of 24 hours by CGM
- Secondary Outcome Measures
Name Time Method